Decker Retirement Planning Inc. bought a new position in shares of The Allstate Co. (NYSE:ALL - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 24,441 shares of the insurance provider's stock, valued at approximately $4,712,000. Allstate accounts for about 2.7% of Decker Retirement Planning Inc.'s investment portfolio, making the stock its 12th biggest position.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pathway Financial Advisers LLC increased its holdings in Allstate by 18,472.5% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider's stock valued at $199,642,000 after buying an additional 1,047,019 shares during the period. Allspring Global Investments Holdings LLC boosted its position in shares of Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider's stock worth $569,114,000 after acquiring an additional 472,040 shares in the last quarter. AQR Capital Management LLC raised its position in Allstate by 181.6% during the second quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider's stock valued at $114,955,000 after purchasing an additional 464,337 shares in the last quarter. TimesSquare Capital Management LLC acquired a new position in Allstate during the third quarter valued at approximately $77,819,000. Finally, Los Angeles Capital Management LLC lifted its stake in Allstate by 688.4% during the third quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider's stock worth $87,292,000 after purchasing an additional 401,901 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Trading Down 0.9 %
Shares of NYSE:ALL traded down $1.71 during trading on Friday, reaching $189.39. The stock had a trading volume of 883,666 shares, compared to its average volume of 2,094,047. The Allstate Co. has a 52 week low of $150.17 and a 52 week high of $209.88. The firm's fifty day moving average is $195.87 and its 200 day moving average is $186.08. The stock has a market cap of $50.15 billion, a price-to-earnings ratio of 12.27, a P/E/G ratio of 1.35 and a beta of 0.52. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business's revenue was up 14.7% compared to the same quarter last year. During the same period last year, the business posted $0.81 EPS. As a group, equities analysts forecast that The Allstate Co. will post 16.45 EPS for the current fiscal year.
Allstate Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were given a dividend of $0.92 per share. The ex-dividend date of this dividend was Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.94%. Allstate's payout ratio is presently 23.83%.
Analyst Ratings Changes
A number of equities analysts have recently commented on the company. Raymond James boosted their price target on Allstate from $205.00 to $220.00 and gave the stock a "strong-buy" rating in a report on Friday, October 4th. Wells Fargo & Company upped their price objective on shares of Allstate from $186.00 to $187.00 and gave the stock an "equal weight" rating in a research report on Tuesday. UBS Group raised their target price on shares of Allstate from $216.00 to $225.00 and gave the company a "buy" rating in a research report on Monday, November 4th. Keefe, Bruyette & Woods raised their price objective on Allstate from $235.00 to $243.00 and gave the company an "outperform" rating in a report on Friday, January 10th. Finally, Barclays dropped their target price on Allstate from $187.00 to $183.00 and set an "underweight" rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $218.13.
View Our Latest Stock Report on ALL
Allstate Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.